Table 1.
Probiotic strain | Probiotic dose | Probiotic treatment duration | Time of probiotic application | Main observations | Reference |
---|---|---|---|---|---|
Akkermansia muciniphila MucT | 3 × 109 CFU/d | 14 d | 7 d before induction of colitis |
Reduced weight loss, colon length shortening and histopathology scores; enhanced gut barrier function Reduced serum and tissue levels of inflammatory cytokines and chemokines Alleviated gut dysbiosis and reshaped the gut microbiota community |
Bain et al.19 |
Lactobacillus paracasei subsp. paracasei NTU 101 | 2.3 × 109 or 4.5 × 109 CFU/kg BW/d | 25 d | 14 d before induction of colitis | Improved antioxidant capacity, reduced pro-inflammatory cytokine levels, increased anti-inflammatory cytokine levels, and slightly ameliorated body weight loss | Chen et al.20 |
Lactobacillus plantarum AR326 | 2 × 109 CFU/d | 7 d | 6 d after induction of colitis |
Reduced body weight loss, disease activity index (DAI), colon length shortening, myeloperoxidase activity and histological damage Restored the tight junction protein expression and reduced the abnormal expression of pro-inflammatory cytokines |
Wang et al.21 |
Bifidobacterium bifidum ATCC 29521 | 2 × 108 CFU/d | 27 d | 21 d before induction of colitis |
Regulated the expression of immune markers and tight junction proteins in the colon Ameliorated expression of selected miRNA, including miR-150, miR-155, and miR-223 Restored healthier gut microbiota from a gut dysbiosis |
Din et al.22 |
Lactobacillus plantarum L15 |
1 × 109 or 1 × 1010 CFU/mL (1 mL/100 g BW) | 28 d | 7 d after induction of colitis |
Increased the body weight, colon length and anti-inflammatory cytokine production Decreased pro-inflammatory cytokine production, DAI levels, and myeloperoxidase parameters Alleviated colonic histopathological changes, modulated the gut microbiota, and decreased lipopolysaccharide secretion Suppressed Toll-like receptor 4-nuclear factor-κB (TLR4-NF-κB) signaling pathway activation |
Yu et al.23 |
Lactobacillus fermentum ZS40 | 1 × 109 CFU/kg BW/d | 35 d | 21 d before induction of colitis |
Reduced histopathology scores, myeloperoxidase and malondialdehyde levels Increased total superoxide dismutase and catalase in mouse serum Regulated the balance of pro-inflammatory cytokines and anti-inflammatory cytokines Inhibited the activation of nuclear factor-κB (NF-κB) and mitogen-activated protein kinase (MAPK) signaling pathways |
Chen et al.24 |
Lactobacillus casei ATCC 393 | 2 × 109 CFU/d | 14 d | 14 d before induction of colitis |
Reduced body weight loss, DAI, colon length shortening, and villus height of colon tissue Inhibited the infiltration of immune cells into the intestinal mucosa, decreased the production of pro-inflammatory factors, and increased serum and colon tissue expression of anti-inflammatory factors Increased the expression levels of occludin, ZO-1, and claudin-1, while reduced the expression of nucleotide binding oligomeric domain-like receptor protein 3 (NLRP3), cysteine proteinase-1 (caspase-1), interleukin (IL)−1β, and IL-18 Improved DSS-induced gut microbiota dysbiosis |
Dou et al.25 |
Saccharomyces boulardii | 1 × 105 or 1 × 107 CFU/d | 21 d | 21 d before induction of colitis |
Reduced DAI, colon length shortening, and loss of histological structure Protected the intestinal barrier, suppressed colonic inflammation, restored myeloperoxidase activity, mitigated colonic oxidative damage Suppressed the nuclear translocation of NF-κB p65 subunit, promoted the nuclear translocation of nuclear factor erythroid 2-related factor 2 (Nrf2) |
Gao et al.26 |
Bifidobacterium Infantis CGMCC0460.1 |
1.5 × 109 CFU/d | 14 d | 7 d before induction of colitis |
Promoted the recovery of intestinal injury and modulated the gut microbiota composition Maintained genome stability partially by upregulating the expression of anaphase-promoting complex subunit 7 (APC7) |
Han et al.27 |
Akkermansia muciniphila ATCC BAA-835 | 1 × 109 CFU/d | 7 d | 7 d before induction of colitis |
Decreased body weight loss, colon length shortening, and colon histological inflammatory score Enhanced the number of goblet cells and the mucin family Downregulated pro-inflammatory cytokines such as tumor necrosis factor alpha (TNF-α), IL-6, and monocyte chemoattractant protein 1 (MCP−1) |
Qu et al.28 |
Lactiplantibacillus plantarum DMDL 9010 | 1 × 107 or 1 × 109 CFU/mL (0.2 mL/10 g BW) | 7 d | At the same time |
Reduced the inflammatory response, repaired intestinal barrier damage, and lightened depression-like behavior Inhibited neuroinflammation by upregulating the levels of neurotransmitters, especially 5-hydroxytryptamine, norepinephrine, dopamine, and 5-hydroxyindole-3-acetic acid Reorganized the gut microbiome and increased the levels of short-chain fatty acids (SCFAs) |
Huang et al.29 |
Lactobacillus acidophilus ATCC 4356 | 1 × 108 CFU/d | 8 d | At the same time |
Decreased DAI scores, improved colon shortening, and protected against splenomegaly and thymic atrophy Increased the contents of SCFAs, inhibited NLRP3 inflammasome and facilitated autophagy |
Li et al.30 |
Clostridium butyricum MIYAIRI II 588 | 1 × 108 CFU/d | 21 d | 21 d before induction of colitis |
Prevented body weight loss, reduced DAI/colon histology scores and colon length shortening, and improved gut barrier function Reduced pathogenic bacteria and increased beneficial bacteria |
Ma et al.31 |
Companilactobacillus crustorum MN047 | 1 × 109 CFU/d | 24 d | 14 d before induction of colitis |
Attenuated the increased DAI, shortened colon length, gut barrier damage, and inflammation Upregulated the expressions of MUCs and tight junctions, downregulated the expressions of pro-inflammatory cytokines and chemokines, increased fecal SCFAs, and lowered serum lipopolysaccharides Regulated gut microbiota (e.g., increased Akkermansia, Blautia, and Ruminococcus levels) |
Wang et al.32 |